Evidence map›Paper›PMID 36515241›Full record

ArticleJournal of the American Heart Association2022

Stroke Outcome Related to Initial Volume Status and Diuretic Use.

Christopher J Renner, Scott E Kasner, Philip M Bath, Mona N Bahouth, VISTA Acute Steering Committee [Link]

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Christopher J RennerUniversity of Pennsylvania Philadelphia PA.ORCID 0000-0002-4457-0895
Scott E KasnerUniversity of Pennsylvania Philadelphia PA.ORCID 0000-0003-0418-6917
Philip M BathStroke Trials Unit, University of Nottingham Nottingham United Kingdom.ORCID 0000-0003-2734-5132
Mona N BahouthJohns Hopkins School of Medicine Baltimore MD.ORCID 0000-0003-0341-5087
VISTA Acute Steering Committee [Link]
University of Nottingham · GBUniversity of Pennsylvania · USJohns Hopkins University · US

Funding

The Philadelphia Regional Stroke Trials Network Coordinating Center (PRSTNCC)U24NS107224 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Brett Lee Cucchiara · 2018 to 2026
$3.2M
The Philadelphia Regional Stroke Trials Network coordinating Center (PRSTNCC)U10NS086474 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI KASNER, SCOTT E · 2013 to 2017
$1.9M
NINDS NIH HHS U10 NS086474NINDS NIH HHS U24 NS107224
6 · The paper itself

Abstract

Background We hypothesized that stroke outcome is related to multiple baseline hydration-related factors including volume contracted state (VCS) and diuretic use. Methods and Results We analyzed a prospective cohort of subjects with ischemic stroke <24 hours of onset enrolled in acute treatment trials within VISTA (Virtual International Stroke Trials Archive). A VCS was defined based on blood urea nitrogen-to-creatinine ratio. The primary end point was modified Rankin Scale score at 90 days. Primary analysis used generalized ordinal logistic regression over the mRS range, adjusted for Totaled Health Risks in Vascular Events score, onset-to-enrollment time, and thrombolytic use. Of 5971 eligible patients with stroke, 42% were taking diuretics at the time of hospitalization, and 44% were in a VCS. Patients in a VCS were older, had more vascular risk factors, were more likely taking diuretics, and had more severe strokes. Diuretic use was associated with both reduced chance of achieving a good functional outcome (odds ratio [OR], 0.57 [95% CI, 0.52-0.63]) and increased mortality at 90 days (OR, 2.30 [95% CI, 2.04-2.61]). VCS was associated with greater mortality 90 days after stroke (OR, 1.53 [95% CI, 1.33-1.76]). There was no evidence of effect modification among the 3 exposures of VCS, diuretic use, or hypokalemia in relation to outcome. Conclusions A VCS at the time of hospitalization was associated with more severe stroke and odds of death but not associated with worse functional outcome when accounting for relevant characteristics. Diuretic use and low serum potassium at the time of stroke onset were associated with worse outcome and may be worthy of further investigation.

Indexed as

DiureticsStrokeFibrinolytic AgentsHumansLogistic ModelsProspective StudiesThrombolytic TherapyTreatment OutcomeDiureticsFibrinolytic Agentsacutediuretichydrationstroke

Identifiers

PMID36515241
PMCPMC9798788
OpenAlexW4311477744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.